TARGETED ANTIGEN LOADED LIPOSOME
Dead / Abandoned — Abandoned — failure to respond (as of 20 Jul 2022)
What this means for you
This application is over — abandoned 07 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90730431
- Mark type
- Stylized text
- Filed
- 24 May 2021
- Abandoned
- 07 Jul 2022
- Attorney of record
- B. Anna McCoy
Goods and services
- Class 001 — Chemicals: Biomedical compounds, namely, peptide substrates used in analyzing and detecting cancer cells for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Synthetic peptides for medical use; synthetic peptides for medical use, namely, synthetic peptides for the treatment of cancer; pharmaceutical preparations for cancer treatments, namely, immunotherapeutic treatments for cancerous tumors; medical preparations, namely, pharmaceuticals containing lipids, liposomes, and peptides for use in the treatment of cancer
- Class 042 — Scientific and technological services: Medical and pharmacological research services in the field of immunotherapy and cancer treatment; biological research, clinical research, and medical research all in the field of immunotherapies and cancer treatment; development of drug delivery agents being made from liposomes and peptides; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations
Owner
- SRI International, Menlo Park, CA, US
Prosecution history
- 20 Jul 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 Jul 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 06 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2022 — NON-FINAL ACTION E-MAILED
- 06 Jan 2022 — NON-FINAL ACTION WRITTEN
- 04 Jan 2022 — ASSIGNED TO EXAMINER
- 19 Aug 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 May 2021 — NEW APPLICATION ENTERED